JAMA Otolaryngol Head Neck Surg:喉部肉毒神经毒素注射能否改善发音障碍引起的工作效率损失?

2021-08-26 AlexYang MedSci原创

发音问题影响工作和生活。痉挛性发音障碍以及肉毒杆菌神经毒素(BoNT)注射治疗对工作效率的影响,目前研究还不透彻。

发音问题影响工作和生活。痉挛性发音障碍以及肉毒杆菌神经毒素(BoNT)注射治疗对工作效率的影响,目前研究还不透彻。

近期,华盛顿大学研究人员在《JAMA Otolaryngol Head Neck Surg》发表论文,评估了痉挛性发音障碍患者在注射BoNT前是否存在发音有关的工作效率损失,以及注射BoNT治疗1个月后是否有工作效率的改善

研究包括了前瞻性病例系列,2015年11月1日到2018年8月30日期间在2个喉科门诊进行,样本为患痉挛性发音障碍已就业的成年人。干预方法为用BoNT注射喉部内肌肉组织。

受试者在注射前完成以下评估工具:工作效率和活动损害问卷(WPAI)、声音障碍指数(VHI)和WorkHoarse。收集了基线人口统计学、合并症和职业用嗓数据。测量结果的变化情况使用配对的2-tailed t检验。调整了人口统计学、合并症和嗓音使用等变量后,探索性亚组分析采用多变量线性回归进行。

共有101名患者入选,75人完成了研究。完成研究的75名参与者的平均(SD)年龄为55.7(11.8)岁,53人(71%)为女性。他们在基线时的平均(SD)发音相关的工作效率损失为43%(27%),注射BoNT后1个月时为22%(23%)(差异,改善20%[27%];95%CI,14%-27%;效应大小,0.74)。

BoNT注射前后相关结果的变化情况

综上所述,痉挛性发音障碍患者确实存在工作效率损失,而使用BoNT注射治疗1个月后,这种损失明显改善。痉挛性发音障碍与工作效率的关联在女性中似乎更强,而BoNT治疗的效果在男性和女性中相当。另外,性别相关的差异仍需验证。

原始出处:

Tanya K Meyer , Charles Spiekerman , Rachel Kaye et al. Association of Laryngeal Botulinum Neurotoxin Injection With Work Productivity for Patients With Spasmodic Dysphonia. JAMA Otolaryngol Head Neck Surg. Aug 2021

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1650960, encodeId=879a1650960df, content=<a href='/topic/show?id=82d74e8850d' target=_blank style='color:#2F92EE;'>#工作效率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47885, encryptionId=82d74e8850d, topicName=工作效率)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26da24104226, createdName=chenshujs, createdTime=Wed Oct 06 04:42:30 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2044200, encodeId=31a7204420064, content=<a href='/topic/show?id=8513126129d' target=_blank style='color:#2F92EE;'>#NEC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12612, encryptionId=8513126129d, topicName=NEC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ac22500003, createdName=1249842em09(暂无昵称), createdTime=Sun Aug 07 14:42:30 CST 2022, time=2022-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058803, encodeId=6b85105880346, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82935628009, createdName=ms3000001458154779, createdTime=Sat Oct 09 08:41:12 CST 2021, time=2021-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011963, encodeId=5d0010119631f, content=哦卡LV, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Fri Aug 27 10:11:10 CST 2021, time=2021-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011782, encodeId=d65f1011e8278, content=棒, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210822/d15a561e055d4cdf98b4abace82dee37/464d5f63a8dd486ab01049225a87f788.jpg, createdBy=7fa65188499, createdName=杨小屁, createdTime=Thu Aug 26 19:14:00 CST 2021, time=2021-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1036805, encodeId=034d103680554, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Thu Aug 26 18:42:30 CST 2021, time=2021-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011751, encodeId=1c7b1011e51b0, content=是受肉毒素美容启发??, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210818/fb5e13970d3f4b33ad2f87e78533b788/2bf64a46b2af4889a9670b2c45628c79.jpg, createdBy=b99c5577202, createdName=仓央嘉措, createdTime=Thu Aug 26 17:31:10 CST 2021, time=2021-08-26, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1650960, encodeId=879a1650960df, content=<a href='/topic/show?id=82d74e8850d' target=_blank style='color:#2F92EE;'>#工作效率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47885, encryptionId=82d74e8850d, topicName=工作效率)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26da24104226, createdName=chenshujs, createdTime=Wed Oct 06 04:42:30 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2044200, encodeId=31a7204420064, content=<a href='/topic/show?id=8513126129d' target=_blank style='color:#2F92EE;'>#NEC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12612, encryptionId=8513126129d, topicName=NEC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ac22500003, createdName=1249842em09(暂无昵称), createdTime=Sun Aug 07 14:42:30 CST 2022, time=2022-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058803, encodeId=6b85105880346, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82935628009, createdName=ms3000001458154779, createdTime=Sat Oct 09 08:41:12 CST 2021, time=2021-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011963, encodeId=5d0010119631f, content=哦卡LV, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Fri Aug 27 10:11:10 CST 2021, time=2021-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011782, encodeId=d65f1011e8278, content=棒, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210822/d15a561e055d4cdf98b4abace82dee37/464d5f63a8dd486ab01049225a87f788.jpg, createdBy=7fa65188499, createdName=杨小屁, createdTime=Thu Aug 26 19:14:00 CST 2021, time=2021-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1036805, encodeId=034d103680554, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Thu Aug 26 18:42:30 CST 2021, time=2021-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011751, encodeId=1c7b1011e51b0, content=是受肉毒素美容启发??, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210818/fb5e13970d3f4b33ad2f87e78533b788/2bf64a46b2af4889a9670b2c45628c79.jpg, createdBy=b99c5577202, createdName=仓央嘉措, createdTime=Thu Aug 26 17:31:10 CST 2021, time=2021-08-26, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1650960, encodeId=879a1650960df, content=<a href='/topic/show?id=82d74e8850d' target=_blank style='color:#2F92EE;'>#工作效率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47885, encryptionId=82d74e8850d, topicName=工作效率)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26da24104226, createdName=chenshujs, createdTime=Wed Oct 06 04:42:30 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2044200, encodeId=31a7204420064, content=<a href='/topic/show?id=8513126129d' target=_blank style='color:#2F92EE;'>#NEC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12612, encryptionId=8513126129d, topicName=NEC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ac22500003, createdName=1249842em09(暂无昵称), createdTime=Sun Aug 07 14:42:30 CST 2022, time=2022-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058803, encodeId=6b85105880346, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82935628009, createdName=ms3000001458154779, createdTime=Sat Oct 09 08:41:12 CST 2021, time=2021-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011963, encodeId=5d0010119631f, content=哦卡LV, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Fri Aug 27 10:11:10 CST 2021, time=2021-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011782, encodeId=d65f1011e8278, content=棒, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210822/d15a561e055d4cdf98b4abace82dee37/464d5f63a8dd486ab01049225a87f788.jpg, createdBy=7fa65188499, createdName=杨小屁, createdTime=Thu Aug 26 19:14:00 CST 2021, time=2021-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1036805, encodeId=034d103680554, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Thu Aug 26 18:42:30 CST 2021, time=2021-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011751, encodeId=1c7b1011e51b0, content=是受肉毒素美容启发??, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210818/fb5e13970d3f4b33ad2f87e78533b788/2bf64a46b2af4889a9670b2c45628c79.jpg, createdBy=b99c5577202, createdName=仓央嘉措, createdTime=Thu Aug 26 17:31:10 CST 2021, time=2021-08-26, status=1, ipAttribution=)]
    2021-10-09 ms3000001458154779

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1650960, encodeId=879a1650960df, content=<a href='/topic/show?id=82d74e8850d' target=_blank style='color:#2F92EE;'>#工作效率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47885, encryptionId=82d74e8850d, topicName=工作效率)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26da24104226, createdName=chenshujs, createdTime=Wed Oct 06 04:42:30 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2044200, encodeId=31a7204420064, content=<a href='/topic/show?id=8513126129d' target=_blank style='color:#2F92EE;'>#NEC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12612, encryptionId=8513126129d, topicName=NEC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ac22500003, createdName=1249842em09(暂无昵称), createdTime=Sun Aug 07 14:42:30 CST 2022, time=2022-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058803, encodeId=6b85105880346, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82935628009, createdName=ms3000001458154779, createdTime=Sat Oct 09 08:41:12 CST 2021, time=2021-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011963, encodeId=5d0010119631f, content=哦卡LV, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Fri Aug 27 10:11:10 CST 2021, time=2021-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011782, encodeId=d65f1011e8278, content=棒, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210822/d15a561e055d4cdf98b4abace82dee37/464d5f63a8dd486ab01049225a87f788.jpg, createdBy=7fa65188499, createdName=杨小屁, createdTime=Thu Aug 26 19:14:00 CST 2021, time=2021-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1036805, encodeId=034d103680554, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Thu Aug 26 18:42:30 CST 2021, time=2021-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011751, encodeId=1c7b1011e51b0, content=是受肉毒素美容启发??, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210818/fb5e13970d3f4b33ad2f87e78533b788/2bf64a46b2af4889a9670b2c45628c79.jpg, createdBy=b99c5577202, createdName=仓央嘉措, createdTime=Thu Aug 26 17:31:10 CST 2021, time=2021-08-26, status=1, ipAttribution=)]
    2021-08-27 查查佳佳

    哦卡LV

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1650960, encodeId=879a1650960df, content=<a href='/topic/show?id=82d74e8850d' target=_blank style='color:#2F92EE;'>#工作效率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47885, encryptionId=82d74e8850d, topicName=工作效率)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26da24104226, createdName=chenshujs, createdTime=Wed Oct 06 04:42:30 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2044200, encodeId=31a7204420064, content=<a href='/topic/show?id=8513126129d' target=_blank style='color:#2F92EE;'>#NEC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12612, encryptionId=8513126129d, topicName=NEC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ac22500003, createdName=1249842em09(暂无昵称), createdTime=Sun Aug 07 14:42:30 CST 2022, time=2022-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058803, encodeId=6b85105880346, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82935628009, createdName=ms3000001458154779, createdTime=Sat Oct 09 08:41:12 CST 2021, time=2021-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011963, encodeId=5d0010119631f, content=哦卡LV, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Fri Aug 27 10:11:10 CST 2021, time=2021-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011782, encodeId=d65f1011e8278, content=棒, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210822/d15a561e055d4cdf98b4abace82dee37/464d5f63a8dd486ab01049225a87f788.jpg, createdBy=7fa65188499, createdName=杨小屁, createdTime=Thu Aug 26 19:14:00 CST 2021, time=2021-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1036805, encodeId=034d103680554, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Thu Aug 26 18:42:30 CST 2021, time=2021-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011751, encodeId=1c7b1011e51b0, content=是受肉毒素美容启发??, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210818/fb5e13970d3f4b33ad2f87e78533b788/2bf64a46b2af4889a9670b2c45628c79.jpg, createdBy=b99c5577202, createdName=仓央嘉措, createdTime=Thu Aug 26 17:31:10 CST 2021, time=2021-08-26, status=1, ipAttribution=)]
    2021-08-26 杨小屁

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1650960, encodeId=879a1650960df, content=<a href='/topic/show?id=82d74e8850d' target=_blank style='color:#2F92EE;'>#工作效率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47885, encryptionId=82d74e8850d, topicName=工作效率)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26da24104226, createdName=chenshujs, createdTime=Wed Oct 06 04:42:30 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2044200, encodeId=31a7204420064, content=<a href='/topic/show?id=8513126129d' target=_blank style='color:#2F92EE;'>#NEC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12612, encryptionId=8513126129d, topicName=NEC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ac22500003, createdName=1249842em09(暂无昵称), createdTime=Sun Aug 07 14:42:30 CST 2022, time=2022-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058803, encodeId=6b85105880346, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82935628009, createdName=ms3000001458154779, createdTime=Sat Oct 09 08:41:12 CST 2021, time=2021-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011963, encodeId=5d0010119631f, content=哦卡LV, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Fri Aug 27 10:11:10 CST 2021, time=2021-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011782, encodeId=d65f1011e8278, content=棒, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210822/d15a561e055d4cdf98b4abace82dee37/464d5f63a8dd486ab01049225a87f788.jpg, createdBy=7fa65188499, createdName=杨小屁, createdTime=Thu Aug 26 19:14:00 CST 2021, time=2021-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1036805, encodeId=034d103680554, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Thu Aug 26 18:42:30 CST 2021, time=2021-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011751, encodeId=1c7b1011e51b0, content=是受肉毒素美容启发??, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210818/fb5e13970d3f4b33ad2f87e78533b788/2bf64a46b2af4889a9670b2c45628c79.jpg, createdBy=b99c5577202, createdName=仓央嘉措, createdTime=Thu Aug 26 17:31:10 CST 2021, time=2021-08-26, status=1, ipAttribution=)]
    2021-08-26 旺医

    顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1650960, encodeId=879a1650960df, content=<a href='/topic/show?id=82d74e8850d' target=_blank style='color:#2F92EE;'>#工作效率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47885, encryptionId=82d74e8850d, topicName=工作效率)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26da24104226, createdName=chenshujs, createdTime=Wed Oct 06 04:42:30 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2044200, encodeId=31a7204420064, content=<a href='/topic/show?id=8513126129d' target=_blank style='color:#2F92EE;'>#NEC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12612, encryptionId=8513126129d, topicName=NEC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ac22500003, createdName=1249842em09(暂无昵称), createdTime=Sun Aug 07 14:42:30 CST 2022, time=2022-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058803, encodeId=6b85105880346, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82935628009, createdName=ms3000001458154779, createdTime=Sat Oct 09 08:41:12 CST 2021, time=2021-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011963, encodeId=5d0010119631f, content=哦卡LV, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Fri Aug 27 10:11:10 CST 2021, time=2021-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011782, encodeId=d65f1011e8278, content=棒, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210822/d15a561e055d4cdf98b4abace82dee37/464d5f63a8dd486ab01049225a87f788.jpg, createdBy=7fa65188499, createdName=杨小屁, createdTime=Thu Aug 26 19:14:00 CST 2021, time=2021-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1036805, encodeId=034d103680554, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Thu Aug 26 18:42:30 CST 2021, time=2021-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011751, encodeId=1c7b1011e51b0, content=是受肉毒素美容启发??, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210818/fb5e13970d3f4b33ad2f87e78533b788/2bf64a46b2af4889a9670b2c45628c79.jpg, createdBy=b99c5577202, createdName=仓央嘉措, createdTime=Thu Aug 26 17:31:10 CST 2021, time=2021-08-26, status=1, ipAttribution=)]
    2021-08-26 仓央嘉措

    是受肉毒素美容启发??

    0

相关资讯

如何提高门诊药房交班及盘点工作效率?

引入FOCUS-PDCA,针对门诊药房交班及盘点工作效率低进行原因分析。

J Rheumatol:识别导致不良工作结局的中轴型脊柱关节炎患者

临床和患者报告的因素以及工作方面均与axSpA患者工作相关结局差的风险升高相关。

J Rheumatol:生物靶向合成药物对银屑病关节炎患者工作效率的影响

使用IFX、GOL、CZP、乌司奴单抗和阿普斯特治疗可以改善自我报告的工作效率。

Occup Environ Med:配自行车和跑步机让员工更健康,工作效率更高

企业的员工在一天中至少有三分之二的时间都在工作场所度过,由于久坐,颈椎疼痛和腰痛困扰着每一位职场人士。

Am J Psychiatry:抗抑郁治疗与工作效率研究

抑郁症又称抑郁障碍,以显著而持久的心境低落为主要临床特征,是心境障碍的主要类型。 抗抑郁药治疗试验中抑郁症状的严重程度是最常见的研究结果,与抑郁症有关的负担仅占一小部分。虽然失去工作效率是抑郁症患者经济负担的最大贡献者,但很少有研究系统地评估治疗对工作效率的独立影响,以及工作效率的变化和长期临床病程之间的关系。 通过工作效率和活动障碍的自我报告问卷重复测量331名参与者的工作效率,这些

Ann Rheum Dis:生物治疗对中轴型脊柱关节炎患者工作结局的影响

有一致的证据表明,生物治疗可以显著改善axSpA患者的工作效率和活动障碍。